• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超越运动缺陷:环境丰富可减轻 YAC128 小鼠亨廷顿病的影响。

Beyond Motor Deficits: Environmental Enrichment Mitigates Huntington's Disease Effects in YAC128 Mice.

机构信息

Neuroscience Graduate Program, Center of Biological Sciences, Federal University of Santa Catarina, Florianopolis 88040-900, SC, Brazil.

Department of Biochemistry, Center of Biological Sciences, Federal University of Santa Catarina, Florianopolis 88040-900, SC, Brazil.

出版信息

Int J Mol Sci. 2023 Aug 9;24(16):12607. doi: 10.3390/ijms241612607.

DOI:10.3390/ijms241612607
PMID:37628801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10454852/
Abstract

Huntington's disease (HD) is a neurodegenerative genetic disorder characterized by motor, psychiatric, cognitive, and peripheral symptoms without effective therapy. Evidence suggests that lifestyle factors can modulate disease onset and progression, and environmental enrichment (EE) has emerged as a potential approach to mitigate the progression and severity of neurodegenerative processes. Wild-type (WT) and yeast artificial chromosome (YAC) 128 mice were exposed to different EE conditions. Animals from cohort 1 were exposed to EE between postnatal days 21 and 60, and animals from cohort 2 were exposed to EE between postnatal days 60 and 120. Motor and non-motor behavioral tests were employed to evaluate the effects of EE on HD progression. Monoamine levels, hippocampal cell proliferation, neuronal differentiation, and dendritic arborization were also assessed. Here we show that EE had an antidepressant-like effect and slowed the progression of motor deficits in HD mice. It also reduced monoamine levels, which correlated with better motor performance, particularly in the striatum. EE also modulated neuronal differentiation in the YAC128 hippocampus. These results confirm that EE can impact behavior, hippocampal neuroplasticity, and monoamine levels in YAC128 mice, suggesting this could be a therapeutic strategy to modulate neuroplasticity deficits in HD. However, further research is needed to fully understand EE's mechanisms and long-term effects as an adjuvant therapy for this debilitating condition.

摘要

亨廷顿病 (HD) 是一种神经退行性遗传疾病,其特征是运动、精神、认知和外周症状,目前尚无有效的治疗方法。有证据表明,生活方式因素可以调节疾病的发作和进展,环境丰富 (EE) 已成为减轻神经退行性过程进展和严重程度的一种潜在方法。野生型 (WT) 和酵母人工染色体 (YAC) 128 小鼠被暴露于不同的 EE 条件下。第 1 组动物在出生后第 21 天至 60 天期间接受 EE,第 2 组动物在出生后第 60 天至 120 天期间接受 EE。采用运动和非运动行为测试来评估 EE 对 HD 进展的影响。还评估了单胺水平、海马细胞增殖、神经元分化和树突分支。我们的研究表明,EE 具有抗抑郁作用,并减缓了 HD 小鼠运动缺陷的进展。它还降低了单胺水平,这与更好的运动表现相关,尤其是在纹状体。EE 还调节了 YAC128 海马中的神经元分化。这些结果证实,EE 可以影响 YAC128 小鼠的行为、海马神经可塑性和单胺水平,表明这可能是一种调节 HD 神经可塑性缺陷的治疗策略。然而,需要进一步的研究来充分了解 EE 作为这种使人衰弱的疾病的辅助治疗的机制和长期效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff4/10454852/3f984a4efad4/ijms-24-12607-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff4/10454852/1517387c6a43/ijms-24-12607-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff4/10454852/4d8535e5c3e9/ijms-24-12607-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff4/10454852/ced242a87050/ijms-24-12607-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff4/10454852/97db3c14742c/ijms-24-12607-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff4/10454852/e07d4bbf6564/ijms-24-12607-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff4/10454852/9f475f4d95bf/ijms-24-12607-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff4/10454852/d9f26b959564/ijms-24-12607-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff4/10454852/3f984a4efad4/ijms-24-12607-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff4/10454852/1517387c6a43/ijms-24-12607-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff4/10454852/4d8535e5c3e9/ijms-24-12607-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff4/10454852/ced242a87050/ijms-24-12607-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff4/10454852/97db3c14742c/ijms-24-12607-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff4/10454852/e07d4bbf6564/ijms-24-12607-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff4/10454852/9f475f4d95bf/ijms-24-12607-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff4/10454852/d9f26b959564/ijms-24-12607-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff4/10454852/3f984a4efad4/ijms-24-12607-g008.jpg

相似文献

1
Beyond Motor Deficits: Environmental Enrichment Mitigates Huntington's Disease Effects in YAC128 Mice.超越运动缺陷:环境丰富可减轻 YAC128 小鼠亨廷顿病的影响。
Int J Mol Sci. 2023 Aug 9;24(16):12607. doi: 10.3390/ijms241612607.
2
'Super-Enrichment' Reveals Dose-Dependent Therapeutic Effects of Environmental Stimulation in a Transgenic Mouse Model of Huntington's Disease.“超富集”揭示了环境刺激在亨廷顿舞蹈病转基因小鼠模型中的剂量依赖性治疗效果。
J Huntingtons Dis. 2014;3(3):299-309. doi: 10.3233/JHD-140118.
3
YAC128 Huntington's disease transgenic mice show enhanced short-term hippocampal synaptic plasticity early in the course of the disease.YAC128亨廷顿舞蹈病转基因小鼠在疾病早期表现出增强的短期海马突触可塑性。
Brain Res. 2014 Sep 18;1581:117-28. doi: 10.1016/j.brainres.2014.06.011. Epub 2014 Jun 17.
4
Brain-Derived Neurotrophic Factor Prevents Depressive-Like Behaviors in Early-Symptomatic YAC128 Huntington's Disease Mice.脑源性神经营养因子可预防早发性 YAC128 亨廷顿病模型小鼠的抑郁样行为。
Mol Neurobiol. 2018 Sep;55(9):7201-7215. doi: 10.1007/s12035-018-0890-6. Epub 2018 Jan 31.
5
Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease.在亨廷顿舞蹈症的YAC128小鼠模型中,认知功能障碍先于神经病理学改变和运动异常出现。
J Neurosci. 2005 Apr 20;25(16):4169-80. doi: 10.1523/JNEUROSCI.0590-05.2005.
6
Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington's Disease.普罗布考对亨廷顿病早期症状 YAC128 转基因小鼠的抗抑郁作用。
Neural Plast. 2018 Aug 14;2018:4056383. doi: 10.1155/2018/4056383. eCollection 2018.
7
Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.突触蛋白失调、树突棘异常以及突触的病理性重塑作为亨廷顿病中经验依赖性认知和精神症状的中介物。
Neuroscience. 2013 Oct 22;251:66-74. doi: 10.1016/j.neuroscience.2012.05.043. Epub 2012 May 24.
8
Small Non-coding RNAs Are Dysregulated in Huntington's Disease Transgenic Mice Independently of the Therapeutic Effects of an Environmental Intervention.小型非编码 RNA 在亨廷顿病转基因小鼠中失调,与环境干预的治疗效果无关。
Mol Neurobiol. 2021 Jul;58(7):3308-3318. doi: 10.1007/s12035-021-02342-9. Epub 2021 Mar 6.
9
Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease.在亨廷顿舞蹈症的YAC128小鼠模型中,反义寡核苷酸介导的转录失调校正与行为改善相关。
J Huntingtons Dis. 2013;2(2):217-28. doi: 10.3233/JHD-130057.
10
Solid Lipid Curcumin Particles Protect Medium Spiny Neuronal Morphology, and Reduce Learning and Memory Deficits in the YAC128 Mouse Model of Huntington's Disease.固体脂质姜黄素颗粒可保护中型棘突神经元形态,并减少亨廷顿病 YAC128 小鼠模型的学习和记忆缺陷。
Int J Mol Sci. 2020 Dec 15;21(24):9542. doi: 10.3390/ijms21249542.

引用本文的文献

1
Circadian Interventions in Preclinical Models of Huntington's Disease: A Narrative Review.亨廷顿舞蹈病临床前模型中的昼夜节律干预:一项叙述性综述
Biomedicines. 2024 Aug 6;12(8):1777. doi: 10.3390/biomedicines12081777.

本文引用的文献

1
New Avenues for the Treatment of Huntington's Disease.治疗亨廷顿病的新途径。
Int J Mol Sci. 2021 Aug 4;22(16):8363. doi: 10.3390/ijms22168363.
2
Beyond the Hippocampus and the SVZ: Adult Neurogenesis Throughout the Brain.超越海马体和室管膜下区:全脑的成年神经发生
Front Cell Neurosci. 2020 Sep 29;14:576444. doi: 10.3389/fncel.2020.576444. eCollection 2020.
3
Early-life environmental enrichment generates persistent individualized behavior in mice.早年环境富集在小鼠中产生持久的个体行为。
Sci Adv. 2020 Aug 26;6(35):eabb1478. doi: 10.1126/sciadv.abb1478. eCollection 2020 Aug.
4
Agmatine potentiates antidepressant and synaptic actions of ketamine: Effects on dendritic arbors and spines architecture and Akt/S6 kinase signaling.胍丁胺增强氯胺酮的抗抑郁和突触作用:对树突分支和棘突结构及 Akt/S6 激酶信号的影响。
Exp Neurol. 2020 Nov;333:113398. doi: 10.1016/j.expneurol.2020.113398. Epub 2020 Jul 10.
5
Patient-reported impact of symptoms in Huntington disease: PRISM-HD.亨廷顿病患者报告的症状影响:PRISM-HD。
Neurology. 2020 May 12;94(19):e2045-e2053. doi: 10.1212/WNL.0000000000008906. Epub 2020 Mar 19.
6
Dopamine and Noradrenaline in the Brain; Overlapping or Dissociate Functions?大脑中的多巴胺与去甲肾上腺素:功能重叠还是分离?
Front Mol Neurosci. 2020 Jan 21;12:334. doi: 10.3389/fnmol.2019.00334. eCollection 2019.
7
Therapeutic Advances for Huntington's Disease.亨廷顿舞蹈症的治疗进展
Brain Sci. 2020 Jan 12;10(1):43. doi: 10.3390/brainsci10010043.
8
Ascorbic acid presents rapid behavioral and hippocampal synaptic plasticity effects.抗坏血酸呈现快速的行为和海马突触可塑性效应。
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 10;96:109757. doi: 10.1016/j.pnpbp.2019.109757. Epub 2019 Aug 30.
9
Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease.瘦素缺乏可逆转亨廷顿病 R6/2 小鼠模型的高代谢状态和体重减轻,而不影响中枢病理学。
Neurobiol Dis. 2019 Dec;132:104560. doi: 10.1016/j.nbd.2019.104560. Epub 2019 Aug 13.
10
Association of CAG Repeats With Long-term Progression in Huntington Disease.CAG重复序列与亨廷顿病长期进展的关联
JAMA Neurol. 2019 Nov 1;76(11):1375-1385. doi: 10.1001/jamaneurol.2019.2368.